KeyBank National Association’s Meridian Bioscience Inc VIVO Stock Holding History

KeyBank National Association’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-10,200	Closed	-$146K	–	1118
2017 Q3	$146K	Hold	10,200	–	–	﹤0.01%	1060
2017 Q2	$161K	Hold	10,200	–	–	﹤0.01%	1069
2017 Q1	$141K	Hold	10,200	–	–	﹤0.01%	1110
2016 Q4	$181K	Sell	10,200 -11,500	-53%	-$202K	﹤0.01%	1095
2016 Q3	$419K	Buy	21,700 +2,700	+14%	+$52.8K	﹤0.01%	876
2016 Q2	$371K	Hold	19,000	–	–	﹤0.01%	881
2016 Q1	$392K	Hold	19,000	–	–	﹤0.01%	849
2015 Q4	$390K	Hold	19,000	–	–	﹤0.01%	862
2015 Q3	$325K	Hold	19,000	–	–	﹤0.01%	929
2015 Q2	$354K	Hold	19,000	–	–	﹤0.01%	957
2015 Q1	$363K	Hold	19,000	–	–	﹤0.01%	955
2014 Q4	$313K	Sell	19,000 -258	-1%	-$4.43K	﹤0.01%	1025
2014 Q3	$341K	Hold	19,258	–	–	﹤0.01%	998
2014 Q2	$397K	Buy	19,258 +123	+0.6%	+$2.53K	﹤0.01%	988
2014 Q1	$417K	Buy	19,135 +135	+0.7%	+$3.09K	﹤0.01%	966
2013 Q4	$504K	Sell	19,000 -275	-1%	-$6.76K	﹤0.01%	907
2013 Q3	$455K	Sell	19,275 -251	-1%	-$5.86K	﹤0.01%	905
2013 Q2	$420K	Buy	+19,526	New	+$421K	﹤0.01%	1042

Other funds holding VIVO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

KeyBank National Association's VIVO Position: Q4 2017 in Review

KeyBank National Association sold out of Meridian Bioscience Inc (VIVO) in Q4 2017, closing a stake of 10,200 shares — an estimated $146K sold.

KeyBank National Association first reported a position in VIVO in Q2 2013 and held it in 18 quarters. The position peaked at $504K in Q4 2013. 178 funds tracked by Wall St. Rank hold VIVO as of Q4 2017.

KeyBank National Association reported no remaining Meridian Bioscience Inc position as of Q4 2017 after selling out during the quarter.
KeyBank National Association sold 10,200 Meridian Bioscience Inc shares in Q4 2017, an estimated $146K.
KeyBank National Association first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 18 quarters.
KeyBank National Association's Meridian Bioscience Inc position peaked at $504K in Q4 2013.
178 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2017.

Based on KeyBank National Association's 13F filing for Q4 2017, filed 8 Feb 2018.